| المؤلف | Mohamed, Mouhand F.H. |
| المؤلف | Elewa, Hazem |
| المؤلف | Mubasher, Mahmood |
| المؤلف | Danjuma, Mohammed |
| تاريخ الإتاحة | 2023-03-28T10:50:24Z |
| تاريخ النشر | 2020-01-01 |
| اسم المنشور | Journal of Thrombosis and Thrombolysis |
| المعرّف | http://dx.doi.org/10.1007/s11239-020-02238-w |
| الاقتباس | Mohamed, M.F.H., Elewa, H., Mubasher, M. et al. Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients. J Thromb Thrombolysis 51, 701–702 (2021). https://doi.org/10.1007/s11239-020-02238-w |
| الرقم المعياري الدولي للكتاب | 09295305 |
| معرّف المصادر الموحد | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088783909&origin=inward |
| معرّف المصادر الموحد | http://hdl.handle.net/10576/41394 |
| الملخص | There has always been unresolved uncertainty regarding the therapeutic utility of direct oral anticoagulants (DOACs) in morbidly obese patients (BMI > 40 kg/m2 or weight > 120 kg) with clinical indications for anticoagulant's use. This is due to the paucity of studies specifically designed to address this uncertainty. This formed the basis of the recommendation, by the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis (2016), against the use of DOACs in morbidly obese patients [1]. |
| اللغة | en |
| الناشر | Springer |
| الموضوع | Direct oral anticoagulants
|
| العنوان | Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients |
| النوع | Article |
| الصفحات | 701-702 |
| رقم المجلد | 51 |
|
dc.accessType
| Abstract Only |
